| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |